ReadYourDNA

Telbivudine (Tyzeka)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Telbivudine

What it is

Telbivudine was a nucleoside analogue antiviral for chronic hepatitis B that blocked the virus's DNA polymerase. It was discontinued around 2016 because resistance developed often and it could cause muscle and nerve side effects; entecavir and tenofovir are used instead. It was sold as Tyzeka and Sebivo.

How genes come into it

Telbivudine is activated inside cells by kinases and cleared unchanged by the kidneys. The gene studies listed looked at TK2 and RRM2B, mitochondrial genes, in relation to its muscle side effects. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Telbivudine. Upload your DNA file to see which of these rows apply to you.

Metabolism (2 findings)

Studies of how quickly the body processes this medication.

TK2 rs3826160: Genotypes CC + CT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.

RRM2B rs2607658: Genotypes GG + GT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Emtriva (NRTIs)

Epivir (NRTIs)

NRTIs (class) (NRTIs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com